MedPath

SUCCINYLCHOLINE CHLORIDE

Succinylcholine Chloride Injection, USP 200 mg/10 mL (20 mg/mL) Rx only

Approved
Approval ID

896a4238-667d-45b0-e053-2a95a90a60dd

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 15, 2023

Manufacturers
FDA

Medical Purchasing Solutions, LLC

DUNS: 601458529

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

SUCCINYLCHOLINE CHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71872-7166
Application NumberANDA211432
Product Classification
M
Marketing Category
C73584
G
Generic Name
SUCCINYLCHOLINE CHLORIDE
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateMay 15, 2023
FDA Product Classification

INGREDIENTS (7)

PROPYLPARABENInactive
Quantity: 0.2 mg in 1 mL
Code: Z8IX2SC1OH
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
METHYLPARABENInactive
Quantity: 1.8 mg in 1 mL
Code: A2I8C7HI9T
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SUCCINYLCHOLINE CHLORIDEActive
Quantity: 20 mg in 1 mL
Code: I9L0DDD30I
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SUCCINYLCHOLINE CHLORIDE - FDA Drug Approval Details